Nicorandil derivatives

HK40067812BActive Publication Date: 2026-09-11UNICYCIVE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62022056980
Authority / Receiving Office
HK · HK
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-03-15
Filing Date
2022-07-19
Publication Date
2026-09-11

AI Technical Summary

Technical Problem

Current treatments for kidney diseases such as Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), and Acute Kidney Failure are often irreversible and require dialysis or transplant, with limited effective pharmaceutical options available.

Method used

Development of pyridyl compounds, including nicorandil derivatives, which can be administered to treat kidney-related conditions by forming nicorandil in vivo, targeting specific kidney diseases and conditions.

Benefits of technology

The compounds effectively prevent, treat, or ameliorate kidney diseases and conditions, including CKD, diabetic nephropathy, and various types of AKI, offering therapeutic benefits without the need for irreversible treatments like transplant.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000056_0000
    Figure 00000056_0000
  • Figure 00000057_0000
    Figure 00000057_0000
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.